Product Code: ETC051381 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Qatar gastrointestinal drugs market experienced steady growth from 2025 to 2031, driven by factors such as the rising prevalence of gastrointestinal disorders, the aging population, and increased healthcare spending on gastrointestinal treatments. Gastrointestinal drugs are medications used to treat various gastrointestinal conditions, such as acid reflux, peptic ulcers, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD).
Several factors have contributed to the growth of the Qatar gastrointestinal drugs market. Firstly, the country`s aging population has led to an increased incidence of gastrointestinal disorders, as older adults are more susceptible to such conditions. Secondly, changing lifestyles, dietary habits, and stress levels have contributed to the rise in gastrointestinal disorders, driving the demand for effective medications. Additionally, government initiatives to improve healthcare infrastructure and access to medical treatments have boosted the availability and use of gastrointestinal drugs.
Despite the positive market trends, the Qatar gastrointestinal drugs industry faces certain challenges. One of the key challenges is the increasing availability and use of generic drugs, which can impact the revenues of branded gastrointestinal medications. Moreover, the complexity of gastrointestinal disorders and the varying response of patients to different treatments pose challenges for physicians in selecting the most suitable drugs. The Market competitive landscape also requires pharmaceutical companies to invest in research and development to bring innovative and effective drugs to the market.
The Covid-19 pandemic had a mixed impact on the Qatar gastrointestinal drugs market. During the initial phases of the pandemic, healthcare facilities faced challenges in managing non-urgent medical conditions, leading to a temporary decline in elective treatments for gastrointestinal disorders. However, as the healthcare system adapted to the pandemic, telemedicine services and home care solutions were employed, leading to a gradual recovery in gastrointestinal drug prescriptions. Moreover, the pandemic highlighted the importance of maintaining gastrointestinal health, leading to increased awareness and preventive measures.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Qatar Gastrointestinal Drugs Market Overview |
3.1 Qatar Country Macro Economic Indicators |
3.2 Qatar Gastrointestinal Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Qatar Gastrointestinal Drugs Market - Industry Life Cycle |
3.4 Qatar Gastrointestinal Drugs Market - Porter's Five Forces |
3.5 Qatar Gastrointestinal Drugs Market Revenues & Volume Share, By Drug Category, 2021 & 2031F |
3.6 Qatar Gastrointestinal Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Qatar Gastrointestinal Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Qatar Gastrointestinal Drugs Market Revenues & Volume Share, By Disease Types, 2021 & 2031F |
4 Qatar Gastrointestinal Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Qatar Gastrointestinal Drugs Market Trends |
6 Qatar Gastrointestinal Drugs Market, By Types |
6.1 Qatar Gastrointestinal Drugs Market, By Drug Category |
6.1.1 Overview and Analysis |
6.1.2 Qatar Gastrointestinal Drugs Market Revenues & Volume, By Drug Category, 2021-2031F |
6.1.3 Qatar Gastrointestinal Drugs Market Revenues & Volume, By Antiemetic, 2021-2031F |
6.1.4 Qatar Gastrointestinal Drugs Market Revenues & Volume, By Acid Neutralizers, 2021-2031F |
6.1.5 Qatar Gastrointestinal Drugs Market Revenues & Volume, By Anti-inflammatory, 2021-2031F |
6.1.6 Qatar Gastrointestinal Drugs Market Revenues & Volume, By Laxatives & Antidiarrheal, 2021-2031F |
6.1.7 Qatar Gastrointestinal Drugs Market Revenues & Volume, By Others, 2021-2031F |
6.2 Qatar Gastrointestinal Drugs Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Qatar Gastrointestinal Drugs Market Revenues & Volume, By Oral, 2021-2031F |
6.2.3 Qatar Gastrointestinal Drugs Market Revenues & Volume, By Parenteral, 2021-2031F |
6.2.4 Qatar Gastrointestinal Drugs Market Revenues & Volume, By Rectal, 2021-2031F |
6.3 Qatar Gastrointestinal Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Qatar Gastrointestinal Drugs Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.3 Qatar Gastrointestinal Drugs Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
6.3.4 Qatar Gastrointestinal Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.4 Qatar Gastrointestinal Drugs Market, By Disease Types |
6.4.1 Overview and Analysis |
6.4.2 Qatar Gastrointestinal Drugs Market Revenues & Volume, By Inflammatory Bowel Diseases, 2021-2031F |
6.4.3 Qatar Gastrointestinal Drugs Market Revenues & Volume, By Gastroesophageal Reflux Diseases, 2021-2031F |
6.4.4 Qatar Gastrointestinal Drugs Market Revenues & Volume, By Others, 2021-2031F |
7 Qatar Gastrointestinal Drugs Market Import-Export Trade Statistics |
7.1 Qatar Gastrointestinal Drugs Market Export to Major Countries |
7.2 Qatar Gastrointestinal Drugs Market Imports from Major Countries |
8 Qatar Gastrointestinal Drugs Market Key Performance Indicators |
9 Qatar Gastrointestinal Drugs Market - Opportunity Assessment |
9.1 Qatar Gastrointestinal Drugs Market Opportunity Assessment, By Drug Category, 2021 & 2031F |
9.2 Qatar Gastrointestinal Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Qatar Gastrointestinal Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Qatar Gastrointestinal Drugs Market Opportunity Assessment, By Disease Types, 2021 & 2031F |
10 Qatar Gastrointestinal Drugs Market - Competitive Landscape |
10.1 Qatar Gastrointestinal Drugs Market Revenue Share, By Companies, 2024 |
10.2 Qatar Gastrointestinal Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |